Skip to content
HomeLatest newsJohnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.
A brick wall at Johnson & Johnson's headquarters

Johnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.

The vaccine is one of three COVID-19 vaccines sharing joint recognition on the list of groundbreaking innovations this year.

Yesterday, the editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time‘s Best Inventions of 2021.

The vaccine, for which Johnson & Johnson received Emergency Use Authorization from the U.S. Food and Drug Administration in February, is being recognized in the Medical Care category alongside two other COVID-19 vaccines.

Since Johnson & Johnson’s founding 135 years ago, it has been committed to using its reach and size for good. In fact, earlier this year, Johnson & Johnson was chosen for inclusion on the first-ever list of TIME100 Most Influential Companies.

Each year, Time highlights groundbreaking inventions across a range of categories—including technology, beauty, healthcare, food, home and entertainment—that are making the world better and smarter and changing the way we live, work, play and think about what’s possible.

Nominations are solicited from editors and correspondents around the world and through an online application process, then evaluated on criteria including originality, creativity, effectiveness, ambition and impact. This year’s list features 100 innovations from around the globe. (You can check out the 2020 winners here.)

Since Johnson & Johnson’s founding 135 years ago, the company has been committed to using its reach and size for good, creating healthier communities and putting a healthy mind, body and environment within reach of everyone, everywhere.

In fact, earlier this year, Johnson & Johnson was chosen for inclusion on the first-ever list of TIME100 Most Influential Companies.

Johnson & Johnson is proud to be named to Time‘s Best Inventions list once again.

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.